Digital Health Trial Uses AI For Better Epilepsy Treatment Decisions

Imagine having to choose from over 14,000 different treatment scenarios to decide which drugs might be best for a child or a loved one affected by epilepsy. This is what faces many families according to the experts at Stanford and doc.ai who have announced a new type of clinical trial using artificial intelligence (AI). The project's goal is to help make the process more scientific using population data and less prone to lengthy individual trial-and-error. Researchers are analyzing medications, side effects, genomic information, environmental exposures, activity and even physical traits. This type of work produces vast amounts of information and requires so much processing power that it can only be performed by the latest AI systems.